KFF Health News March 21, 2024
Michael Scaturro

Online stores sprang up during the covid-19 pandemic’s telehealth boom touting testosterone as a cure-all for men’s age-related illnesses — despite FDA rules issued years ago restricting such “low testosterone” advertising.

In ads on Google, Facebook, and elsewhere, testosterone telemedicine websites may promise a quick fix for sluggishness and low libido in men. But evidence for that is lacking, physicians said, and the midlife malaise for which testosterone is being touted as a solution is more likely caused by chronic medical conditions, poor diet, or a sedentary lifestyle. In fact, doctors urge caution — and the FDA recommends that all testosterone supplements carry a warning that they may increase the risk of heart attack and stroke.

Valid medical reasons do...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology, Telehealth
Remote patient monitoring in 2025: The major changes physicians need to know about
Another Reprieve? Proposed Budget Bill Includes Telehealth, HaH Extensions
House expected to consider CR to fund government through Sept. 30, extend key health care provisions
3 million Americans live where even telehealth can't reach: 6 notes
DEA role must be clearly defined in controlled substance Rx via telemedicine, expert cautions

Share This Article